Who owns HALOZYME THERAPEUTICS INC NOTE 1.000 8/1?
- CUSIP Number: 40637haf6
Tip: Access positions for across all investors
Analyze quarterly positions in Halozyme Therapeutics Inc Note 1.000 8/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Halozyme Therapeutics Inc Note 1.000 8/1 stock
Who bought or sold HALOZYME THERAPEUTICS INC NOTE 1.000 8/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| M&G | 24B | $98M | 2% | Sep 2024 |
|
| Citadel Advisors | 58M | $70M | 342% | Sep 2024 |
|
| MacKay Shields | 45M | $53M | 0% | Sep 2024 |
|
| Lazard Asset Management | 42M | $50M | -1% | Sep 2024 |
|
| Calamos Advisors | 40M | $48M | -37% | Sep 2024 |
|
| Polar Securities | 40M | $48M | 100% | Sep 2024 |
|
| BlackRock | 35M | $39M | 544% | Jun 2024 |
|
| Wolverine Asset Management | 19M | $23M | -59% | Sep 2024 |
|
| Ing Investment Management | 18M | $22M | 26% | Sep 2024 |
|
| Wells Fargo & Company | 17M | $20M | 29% | Sep 2024 |
|
| CNH Partners | 16M | $19M | 15% | Sep 2024 |
|
| State Street Corporation | 15M | $16M | -7% | Jun 2024 |
|
| BlackRock | 13M | $16M | 100% | Sep 2024 |
|
| Absolute Investment Advisers | 11M | $13B | 0% | Sep 2024 |
|
| Glazer Capital | 11M | $13M | 100% | Sep 2024 |
|
| Kohlberg Kravis Roberts & Co | 10M | $11M | 0% | Jun 2024 |
|
| Schroder Investment Management Group | 9.9M | $11M | 3% | Jun 2024 |
|
| Morgan Stanley | 9.2M | $10M | 0% | Jun 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 8.7M | $10M | 0% | Sep 2024 |
|
| Franklin Resources | 8.6M | $9.8M | 33% | Sep 2024 |
|
| Citigroup | 8.0M | $9.5M | 100% | Sep 2024 |
|
| SSI Investment Management | 7.9M | $9.4M | 67% | Sep 2024 |
|
| Jpmorgan Chase & Co | 7.8M | $9.3M | 130% | Sep 2024 |
|
| Amundi | 7.5M | $8.6M | -6% | Sep 2024 |
|
| Shenkman Capital Management | 5.6M | $6.7B | 2% | Sep 2024 |
|
| Ofi Invest Asset Management | 4.9M | $5.1M | 0% | Jun 2024 |
|
| Oaktree Capital Management | 4.8M | $5.7M | 33% | Sep 2024 |
|
| Bank of America Corporation | 4.4M | $5.2M | -76% | Sep 2024 |
|
| RWC Asset Management | 4.0M | $4.8M | 0% | Sep 2024 |
|
| Susquehanna International | 4.0M | $4.8M | 100% | Sep 2024 |
|
| Angelo, Gordon & Co | 3.8M | $4.5M | 100% | Sep 2024 |
|
| Gabelli Funds | 3.6M | $4.3M | -54% | Sep 2024 |
|
| Invesco | 3.5M | $4.1M | 0% | Sep 2024 |
|
| Royal Bank of Canada | 3.1M | $3.6M | -6% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 2.9M | $3.5M | 39% | Sep 2024 |
|
| Nicholas Investments Partners | 2.7M | $3.2M | 100% | Sep 2024 |
|
| Palisade Capital Management | 2.6M | $2.9M | -28% | Jun 2024 |
|
| Man Group | 2.4M | $2.8M | -17% | Sep 2024 |
|
| Sonora Investment Management Group | 2.3M | $2.7M | -2% | Sep 2024 |
|
| Westwood Holdings | 2.3M | $267M | 0% | Sep 2024 |
|
| Macquarie Group | 1.7M | $1.9M | -37% | Jun 2024 |
|
| Agf Management | 1.5M | $1.8M | 0% | Sep 2024 |
|
| Flossbach Von Storch | 1.4M | $1.7M | -22% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 1.2M | $1.5M | -51% | Sep 2024 |
|
| Barclays | 1.2M | $1.4M | -62% | Sep 2024 |
|
| Prospector Partners | 1.2M | $1.3M | 20% | Jun 2024 |
|
| Wellesley Investment Advisors | 1.0M | $1.2B | -29% | Sep 2024 |
|
| Zurcher Kantonalbank | 500k | $585k | 0% | Sep 2024 |
|
| Central Pacific Bank - Trust Division | 435k | $517k | 87% | Sep 2024 |
|
| Russell Investments | 428k | $478k | 0% | Jun 2024 |
|
| Bank of New York Mellon | 400k | $477k | -33% | Sep 2024 |
|
| Dnca Finance | 400k | $477k | 100% | Sep 2024 |
|
| Sei Investments | 322k | $382k | 0% | Sep 2024 |
|
| Teton Advisors | 300k | $357k | -40% | Sep 2024 |
|
| Sunrise Partners Limited Partnership | 225k | $268k | 100% | Sep 2024 |
|
| KBC Group NV | 200k | $239k | 0% | Sep 2024 |
|
| Oppenheimer Asset Management | 176k | $209k | -5% | Sep 2024 |
|
| First Hawaiian Bank | 124k | $147k | 121% | Sep 2024 |
|
| Advent Capital Management | 115k | $137k | -100% | Sep 2024 |
|
| Stephens | 95k | $113k | -7% | Sep 2024 |
|
| Lake Street Advisors Group | 33k | $39k | 22% | Sep 2024 |
|
| Balboa Wealth Partners | 31k | $37k | -3% | Sep 2024 |
|
| Oaktree Fund Advisors | 22k | $26k | 100% | Sep 2024 |
|
| Leucadia National Corporation | 22k | $25k | -99% | Jun 2024 |
|
| Boussard & Gavaudan Investment Management | 7.0k | $7.8M | 100% | Jun 2024 |
|
| Nomura Holdings | 6.4k | $367k | 100% | Sep 2024 |
|
| Us Bancorp | 5.0k | $5.9k | 100% | Sep 2024 |
|
| Brian McDonald | 5.0k | $5.9k | 150% | Sep 2024 |
|
| Alken Asset Management | 1.3k | $1.5M | 0% | Sep 2024 |
|
| Candriam Luxembourg S.C.A. | 1.1k | $1.2M | -21% | Jun 2024 |
|
Who sold out of Halozyme Therapeutics Inc Note 1.000 8/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 42M | $47M |
| Magnetar Financial | Mar 2024 | 16M | $16M |
| New York State Common Retirement Fund | Jun 2024 | 3.9M | $4.3M |
| Groupama Asset Managment | Jun 2024 | 1.2M | $1.3M |
| Aviva | Mar 2024 | 750k | $729k |
| Calamos Wealth Management | Jun 2024 | 365k | $406k |
| Rsm Us Wealth Management | Jun 2024 | 19k | $21k |